Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Burlington Northern Santa Fe Railroad Company v. EEOC (1)
- Consent (1)
- Consent procedures (1)
- Employment and insurance law (1)
- Fair discrimination (1)
-
- Forcible medication (1)
- Foster care (1)
- Genetic Information Nondiscrimination Act (GINA) (1)
- Genetics research (1)
- Mentally ill children (1)
- Model consent form (1)
- Norman-Bloodsaw v. Lawrence Berkeley Laboratory (1)
- Oversight (1)
- Parents (1)
- Pediatricians (1)
- Psychiatrists (1)
- Psychotropic medication (1)
- Right of refusal (1)
- Risk profiles and classification (1)
- Social service agncies (1)
- State reporting and monitoring (1)
Articles 1 - 2 of 2
Full-Text Articles in Medical Jurisprudence
The Dangers Of Psychotropic Medication For Mentally Ill Children: Where Is The Child’S Voice In Consenting To Medication? An Empirical Study, Donald H. Stone
The Dangers Of Psychotropic Medication For Mentally Ill Children: Where Is The Child’S Voice In Consenting To Medication? An Empirical Study, Donald H. Stone
All Faculty Scholarship
When a child with a mental illness is being prescribed psychotropic medication. who decides whether the child should take the medication — the parent or the child? What if the child is sixteen years of age? What if the child is in foster care: Should the parent or social service agency decide? Prior to administering psychotropic medication, what specific information should be provided to the person authorized to consent on behalf of the child? Should children be permitted to refuse psychotropic medications? If so, at what age should a child he able to refuse such medication What procedures should be …
Health Insurance, Employment, And The Human Genome: Genetic Discrimination And Biobanks In The United States, Eric A. Feldman, Chelsea Darnell
Health Insurance, Employment, And The Human Genome: Genetic Discrimination And Biobanks In The United States, Eric A. Feldman, Chelsea Darnell
All Faculty Scholarship
Does genetic information warrant special legal protection, and if so how should it be protected? This essay examines the most recent (and indeed only) significant effort by the US government to prohibit genetic discrimination, the Genetic Information Nondiscrimination Act (GINA). We argue that the legislation is unlikely to have the positive impact sought by advocates of genetic privacy and proponents of biobanks. In part, GINA disappoints because it does too little. Hailed by its promoters as “the first civil rights act of the 21st century,” GINA’s reach is in fact quite modest and its grasp even more so. But …